Literature DB >> 14452236

Clinical trial of methoserpidine in general practice.

D L JONES, A M MICHAEL, J P OMMER.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; RAUWOLFIA/therapy

Mesh:

Substances:

Year:  1961        PMID: 14452236      PMCID: PMC1970934          DOI: 10.1136/bmj.2.5269.1738

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  [A new non-depressive hypotensive drug: 10-methoxydeserpidine].

Authors:  P MERIEL; F GALINIER; J M SUC; J PUTOIS; J P BOUNHOURE
Journal:  Sem Med Prof Med Soc       Date:  1959 Jul 20-30

2.  Rescinnamine in treatment of hypertension in hospital clinic and in general practice.

Authors:  R FIFE; J C MACLAURIN; J H WRIGHT
Journal:  Br Med J       Date:  1960-12-24

3.  An isomer of reserpine--report of a clinical trial of a new hypotensive substance.

Authors:  F H READ
Journal:  Med J Aust       Date:  1961-02-18       Impact factor: 7.738

4.  [Testing of various doses of a non-sedative derivative of reserpine, R 694, in the therapy of arterial hypertension].

Authors:  H GROS; M PETERFALVI; R JEQUIER
Journal:  Alger Medicale       Date:  1959-03

5.  [Cleavage of the reserpine-like properties of some reserpine derivatives].

Authors:  L VELLUZ; M PETERFALVI; R JEQUIER
Journal:  C R Hebd Seances Acad Sci       Date:  1958-11-24

6.  Some observations on the pharmacology of 10-methoxydeserpidine.

Authors:  B J MIR; J J LEWIS
Journal:  J Pharm Pharmacol       Date:  1960-11       Impact factor: 3.765

7.  [Relations between the chemical structure of Rauwolfia derivatives and their pharmacodynamic properties].

Authors:  J LA BARRE
Journal:  Thorax       Date:  1960       Impact factor: 9.139

8.  [Therapeutic trials of 10-methoxy-deserpidine in the treatment of arterial hypertension].

Authors:  F BRUN; J RONDELET
Journal:  Lyon Med       Date:  1959-11-15

9.  The treatment of primary Raynaud's disease of the upper limb.

Authors:  J H PEACOCK
Journal:  Lancet       Date:  1960-07-09       Impact factor: 79.321

10.  [Clinical study of the activity of a new hypotensive agent: 10-methoxydeserpidine or R-694].

Authors:  R TRICOT; D COLONNA; B ALDERETE
Journal:  Presse Med       Date:  1960-05-14       Impact factor: 1.228

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.